Tantalus Systems has been added to the Nasdaq OMX Clean Edge Smart Grid Infrastructure Index as of September 21, 2026. This inclusion means Tantalus is now part of the First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund, which tracks the index and manages about $12.1 billion in assets. The move enhances Tantalus' exposure to investors focused on smart grid modernization and energy infrastructure. Tantalus provides data-driven solutions to help utilities modernize their electric distribution grids, supporting over 340 utility partners across North America. This listing reflects Tantalus' growing role in the smart grid sector and may attract more investment as utilities face increasing demands for grid modernization and electrification.
Tantalus Systems' addition to the Nasdaq OMX Clean Edge Smart Grid Infrastructure Index provides context for readers following smart grid developments. For readers following Utilities-sector US stocks on Pluang, here is the market snapshot as of Sep 25, 2026 02:51 WIB: out of 22 priced stocks, 3 rose and 19 fell. Notable movers include FirstEnergy Corp. (FE) at USD 43.23 with a 1-day change of -0.97% and 100% buy order activity, American Water Works Company Inc (AWK) at USD 131.78 with a 1-day change of -0.96% and 100% buy order activity, and Sempra Energy (SRE) at USD 77.73 with a 1-day change of -0.81%. The most notable figure is the 100% buy order activity for FE and AWK.
Costco reported a strong Q4 earnings per share (EPS) of $6.75, surpassing analyst expectations of $6.54, helped by tariff refunds. Although quarterly revenue of $93.87 billion slightly missed the $94.97 billion forecast, net sales rose 11.2% year-ove...
Vistry Group reported a significant first-half pre-tax loss of £661.3 million, driven by a £475 million goodwill impairment and increased building safety costs. Revenue fell to £1.42 billion, and operational performance weakened with fewer home compl...
Vail Resorts is set to report its Q3 2026 earnings on September 28, with analysts forecasting a loss per share around -$5.30 and revenue near $271 million, indicating flat performance year-over-year. The company’s financial health shows a high Debt-t...
REGENXBIO announced positive 3-year results from its Phase II ALTITUDE trial of surabgene lomparvovec (sura-vec) for non-proliferative diabetic retinopathy (NPDR). A single in-office gene therapy dose led to over 60% of participants achieving more th...
Ethereum (ETH) has printed its first higher high since its August 2025 peak, breaking a year-long pattern of lower highs. It surpassed the $2,438 resistance level, which has now turned into support, signaling a more bullish weekly structure. However,...
